Sotera Health's earnings call highlighted strong financial performance, particularly in revenue growth and debt reduction, alongside significant achievements like Nordion's license renewal. However, challenges remain with Nelson Labs' revenue decline and ongoing litigation in Georgia.

Company Guidance

During the Sotera Health Third Quarter 2025 Conference Call, the company reported strong financial performance with a 9.1% increase in total revenues and a 12.2% increase in adjusted EBITDA compared to the third quarter of 2024. Adjusted EBITDA margins expanded by approximately 150 basis points, reaching 52.7%. The company also achieved a $0.09 increase in adjusted EPS. Sterigenics contributed significantly with 9.8% revenue growth, while Nordion saw a substantial 22.4% increase in revenues. Despite Nelson Labs' revenue being modestly below expectations, there was segment income growth and margin expansion. Sotera Health also strengthened its balance sheet by paying down $75 million in debt, resulting in annual interest savings of approximately $13 million. For the full year 2025, the company reaffirmed its revenue outlook and raised its adjusted EBITDA growth outlook, highlighting its resilience and commitment to sustainable growth in the healthcare sector.

Strong Financial Performance

Sotera Health reported a 9.1% increase in total company revenues and a 12.2% increase in adjusted EBITDA for the third quarter of 2025. Adjusted EPS increased by $0.09 compared to the third quarter of 2024.

Sterigenics Revenue Growth

Sterigenics achieved 9.8% top line growth driven by favorable volume mix and increased pricing.

Nordion's Significant Revenue Increase

Nordion delivered revenue growth of 22.4%, driven by volume and mix benefit and favorable pricing.

Strong Balance Sheet and Debt Reduction

The company paid down $75 million of debt, reducing interest expenses by approximately $13 million annually.

Nordion License Renewal

Nordion secured a 25-year renewal of its Class 1B operating license, ensuring a reliable supply of Cobalt-60.

Sotera Health (SHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

SHC Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Mar 03, 2026	2025 (Q4)	0.24 / -	0.21	―	―	―
Nov 04, 2025	2025 (Q3)	0.22 / 0.26	0.17	52.94% (+0.09)
Aug 08, 2025	2025 (Q2)	0.17 / 0.20	0.19	5.26% (+0.01)
May 01, 2025	2025 (Q1)	0.12 / 0.14	0.13	7.69% (+0.01)
Feb 27, 2025	2024 (Q4)	0.20 / 0.21	0.26	-19.23% (-0.05)
Nov 05, 2024	2024 (Q3)	0.18 / 0.17	0.21	-19.05% (-0.04)
Aug 05, 2024	2024 (Q2)	0.17 / 0.19	0.21	-9.52% (-0.02)
May 02, 2024	2024 (Q1)	0.12 / 0.13	0.13	0.00% (0.00)
Feb 27, 2024	2023 (Q4)	0.26 / 0.26	0.25	4.00% (+0.01)
Nov 01, 2023	2023 (Q3)	0.20 / 0.21	0.23	-8.70% (-0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

SHC Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 04, 2025	$16.61	$16.43	-1.08%
Aug 08, 2025	$11.22	$13.97	+24.51%
May 01, 2025	$11.50	$12.10	+5.22%
Feb 27, 2025	$13.64	$12.28	-9.97%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sotera Health Company (SHC) report earnings?

Sotera Health Company (SHC) is schdueled to report earning on Mar 03, 2026, Before Open (Confirmed).

What is Sotera Health Company (SHC) earnings time?

Sotera Health Company (SHC) earnings time is at Mar 03, 2026, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is SHC EPS forecast?

SHC EPS forecast for the fiscal quarter 2025 (Q4) is 0.24.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing